← All organizations

GOG Foundation, Inc.

Academic/Hospital

Also known as: GOG Foundation | GOG Foundation, Inc. | GOG Foundation, Inc. (GOG Foundation) | The GOG Foundation, Inc.

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Last known activity

Mar 5, 2026

Timeline

No events for the selected filters.

Drugs by trial phase (56 distinct, 32 trials)

Phase 3 (38 own, 0 via acquisition)

Phase 2 (17 own, 0 via acquisition)

Phase 1 (1 own, 0 via acquisition)

nxp800

Indications

Studied for

Recent trials (38)

NCT07286331CollaboratorPhase 3Mar 5, 2026
NCT07286266CollaboratorPhase 3Mar 3, 2026
NCT07214779CollaboratorPhase 3Dec 1, 2025
NCT07218809CollaboratorPhase 3Nov 28, 2025
NCT06890338CollaboratorPhase 2Nov 21, 2025
NCT07023627CollaboratorPhase 2Nov 12, 2025
NCT07213804CollaboratorPhase 3Oct 22, 2025
NCT06824467CollaboratorPhase 3Apr 9, 2025
NCT06463028CollaboratorPhase 2Dec 31, 2024
NCT06486441CollaboratorPhase 3Aug 28, 2024
NCT06459180CollaboratorPhase 3Jul 24, 2024
NCT06072781OfficialPhase 3Dec 31, 2023
NCT06072781CollaboratorPhase 3Dec 31, 2023
NCT06099418CollaboratorPhase 2Dec 31, 2023
NCT06072781Overall official - principal investigatorPhase 3Dec 31, 2023

Details

Last known activity: Mar 5, 2026